KNTE Insider Transactions
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2024-04-03 | Tananbaum James B. | director, 10 percent owner: | 0 | D-Return | D | 520,711 | 2.59 | 1,347,548.00 |
| 2024-04-03 | Tananbaum James B. | director, 10 percent owner: | 0 | D-Return | D | 40,501 | 20.00 | 810,020.00 |
| 2024-04-03 | Tananbaum James B. | director, 10 percent owner: | 0 | D-Return | D | 20,250 | 8.38 | 169,695.00 |
| 2024-04-03 | Farzan Nima | director, officer: CHIEF EXECUTIVE OFFICER | 0 | D-Return | D | 2,186 | 2.59 | 5,657.00 |
| 2024-04-03 | Farzan Nima | director, officer: CHIEF EXECUTIVE OFFICER | 0 | D-Return | D | 1,281,642 | 2.57 | 3,293,820.00 |
| 2024-04-03 | Farzan Nima | director, officer: CHIEF EXECUTIVE OFFICER | 0 | D-Return | D | 437,413 | 5.63 | 2,462,635.00 |
| 2024-04-03 | Farzan Nima | director, officer: CHIEF EXECUTIVE OFFICER | 0 | D-Return | D | 275,000 | 35.38 | 9,729,500.00 |
| 2024-04-03 | Farzan Nima | director, officer: CHIEF EXECUTIVE OFFICER | 0 | D-Return | D | 400,000 | 10.03 | 4,012,000.00 |
| 2024-04-03 | Farzan Nima | director, officer: CHIEF EXECUTIVE OFFICER | 0 | D-Return | D | 750,000 | 6.78 | 5,085,000.00 |
| 2024-04-03 | MITCHELL DEAN J | director | 0 | D-Return | D | 121,503 | 5.63 | 684,062.00 |
| 2024-04-03 | MITCHELL DEAN J | director | 0 | D-Return | D | 20,250 | 24.46 | 495,315.00 |
| 2024-04-03 | MITCHELL DEAN J | director | 0 | D-Return | D | 20,250 | 8.38 | 169,695.00 |
| 2024-04-03 | MITCHELL DEAN J | director | 0 | D-Return | D | 25,000 | 3.48 | 87,000.00 |
| 2024-04-03 | Krishnamohan Neha | officer: CHIEF FINANCIAL OFFICER | 0 | D-Return | D | 64,087 | 2.59 | 165,851.00 |
| 2024-04-03 | Krishnamohan Neha | officer: CHIEF FINANCIAL OFFICER | 0 | D-Return | D | 270,000 | 23.26 | 6,280,200.00 |
| 2024-04-03 | Krishnamohan Neha | officer: CHIEF FINANCIAL OFFICER | 0 | D-Return | D | 185,000 | 10.03 | 1,855,550.00 |
| 2024-04-03 | Krishnamohan Neha | officer: CHIEF FINANCIAL OFFICER | 0 | D-Return | D | 215,000 | 6.78 | 1,457,700.00 |
| 2024-04-03 | Smaldone Alsup Laurie | director | 0 | D-Return | D | 60,751 | 5.63 | 342,028.00 |
| 2024-04-03 | Smaldone Alsup Laurie | director | 0 | D-Return | D | 20,250 | 24.46 | 495,315.00 |
| 2024-04-03 | Smaldone Alsup Laurie | director | 0 | D-Return | D | 20,250 | 8.38 | 169,695.00 |
| 2024-04-03 | Smaldone Alsup Laurie | director | 0 | D-Return | D | 25,000 | 3.48 | 87,000.00 |
| 2024-04-03 | Epperly Melissa B, | director | 0 | D-Return | D | 60,751 | 8.39 | 509,701.00 |
| 2024-04-03 | Epperly Melissa B, | director | 0 | D-Return | D | 20,250 | 8.38 | 169,695.00 |
| 2024-04-03 | Epperly Melissa B, | director | 0 | D-Return | D | 25,000 | 3.48 | 87,000.00 |
| 2024-04-03 | Epperly Melissa B, | director | 0 | D-Return | D | 20,250 | 24.46 | 495,315.00 |
| 2024-04-03 | Flaherty Keith T. | director | 0 | D-Return | D | 66,377 | 2.59 | 171,777.00 |
| 2024-04-03 | Flaherty Keith T. | director | 0 | D-Return | D | 32,064 | 0.18 | 5,772.00 |
| 2024-04-03 | Flaherty Keith T. | director | 0 | D-Return | D | 56,112 | 2.57 | 144,208.00 |
| 2024-04-03 | Flaherty Keith T. | director | 0 | D-Return | D | 11,391 | 5.63 | 64,131.00 |
| 2024-04-03 | Flaherty Keith T. | director | 0 | D-Return | D | 20,250 | 24.46 | 495,315.00 |
| 2024-04-03 | Flaherty Keith T. | director | 0 | D-Return | D | 20,250 | 8.38 | 169,695.00 |
| 2024-04-03 | Flaherty Keith T. | director | 0 | D-Return | D | 25,000 | 3.48 | 87,000.00 |
| 2024-04-03 | Rome Michael E | director | 0 | D-Return | D | 40,501 | 20.00 | 810,020.00 |
| 2024-04-03 | Rome Michael E | director | 0 | D-Return | D | 20,250 | 8.38 | 169,695.00 |
| 2024-04-03 | Sabzevari Helen | director | 0 | D-Return | D | 40,501 | 24.38 | 987,414.00 |
| 2024-04-03 | Sabzevari Helen | director | 0 | D-Return | D | 25,000 | 3.48 | 87,000.00 |
| 2024-04-03 | Sabzevari Helen | director | 0 | D-Return | D | 20,250 | 8.38 | 169,695.00 |
| 2024-04-03 | DeSimone Jill | director | 0 | D-Return | D | 50,000 | 5.21 | 260,500.00 |
| 2024-04-03 | Meltz Mark A | officer: COO GENERAL COUNSEL SECRETARY | 0 | D-Return | D | 27,578 | 2.59 | 71,369.00 |
| 2024-04-03 | Meltz Mark A | officer: COO GENERAL COUNSEL SECRETARY | 0 | D-Return | D | 384,508 | 2.57 | 988,186.00 |
| 2024-04-03 | Meltz Mark A | officer: COO GENERAL COUNSEL SECRETARY | 0 | D-Return | D | 121,503 | 5.63 | 684,062.00 |
| 2024-04-03 | Meltz Mark A | officer: COO GENERAL COUNSEL SECRETARY | 0 | D-Return | D | 100,000 | 35.38 | 3,538,000.00 |
| 2024-04-03 | Meltz Mark A | officer: COO GENERAL COUNSEL SECRETARY | 0 | D-Return | D | 135,000 | 10.03 | 1,354,050.00 |
| 2024-04-03 | Meltz Mark A | officer: COO GENERAL COUNSEL SECRETARY | 0 | D-Return | D | 215,000 | 6.78 | 1,457,700.00 |
| 2024-04-03 | GORDON CARL L | director, 10 percent owner: | 0 | D-Return | D | 450,000 | 2.59 | 1,164,555.00 |
| 2024-04-03 | GORDON CARL L | director, 10 percent owner: | 0 | D-Return | D | 40,501 | 20.00 | 810,020.00 |
| 2024-04-03 | GORDON CARL L | director, 10 percent owner: | 0 | D-Return | D | 20,250 | 8.38 | 169,695.00 |
| 2024-04-03 | GORDON CARL L | director, 10 percent owner: | 0 | D-Return | D | 25,000 | 3.48 | 87,000.00 |
| 2024-04-03 | ORBIMED ADVISORS LLC | director, 10 percent owner: | 0 | D-Return | D | 450,000 | 2.59 | 1,164,555.00 |
| 2024-04-03 | Foresite Capital Management IV, LLC | 10 percent owner | 0 | D-Return | D | 520,711 | 2.59 | 1,347,548.00 |
| 2024-03-01 | Krishnamohan Neha | officer: CHIEF FINANCIAL OFFICER | 64,087 | F-InKind | D | 1,506 | 2.59 | 3,901.00 |
| 2024-03-01 | Meltz Mark A | officer: COO GENERAL COUNSEL SECRETARY | 27,578 | F-InKind | D | 558 | 2.59 | 1,445.00 |
| 2024-03-01 | Williams Richard Thomas | officer: CHIEF MEDICAL OFFICER | 67,588 | F-InKind | D | 558 | 2.59 | 1,445.00 |
| 2023-12-01 | Williams Richard Thomas | officer: Chief Medical Officer | 68,146 | F-InKind | D | 541 | 2.25 | 1,217.00 |
| 2023-12-01 | Krishnamohan Neha | officer: Chief Financial Officer | 65,593 | F-InKind | D | 1,459 | 2.25 | 3,283.00 |
| 2023-12-01 | Meltz Mark A | officer: COO General Counsel Secretary | 28,136 | F-InKind | D | 541 | 2.25 | 1,217.00 |
| 2023-09-01 | Krishnamohan Neha | officer: Chief Financial Officer | 67,052 | F-InKind | D | 1,459 | 2.35 | 3,429.00 |
| 2023-09-01 | Meltz Mark A | officer: COO General Counsel Secretary | 28,677 | F-InKind | D | 541 | 2.35 | 1,271.00 |
| 2023-09-01 | Williams Richard Thomas | officer: Chief Medical Officer | 68,687 | F-InKind | D | 541 | 2.35 | 1,271.00 |
| 2023-06-12 | Sabzevari Helen | director | 25,000 | A-Award | A | 25,000 | 3.48 | 87,000.00 |
| 2023-06-12 | Smaldone Alsup Laurie | director | 25,000 | A-Award | A | 25,000 | 3.48 | 87,000.00 |
| 2023-06-12 | MITCHELL DEAN J | director | 25,000 | A-Award | A | 25,000 | 3.48 | 87,000.00 |
| 2023-06-12 | GORDON CARL L | director, 10 percent owner: | 25,000 | A-Award | A | 25,000 | 3.48 | 87,000.00 |
| 2023-06-12 | Flaherty Keith T. | director | 25,000 | A-Award | A | 25,000 | 3.48 | 87,000.00 |
| 2023-06-12 | Epperly Melissa B, | director | 25,000 | A-Award | A | 25,000 | 3.48 | 87,000.00 |
| 2023-06-01 | Williams Richard Thomas | officer: Chief Medical Officer | 69,228 | F-InKind | D | 541 | 4.30 | 2,326.00 |
| 2023-06-01 | Meltz Mark A | officer: COO General Counsel Secretary | 29,218 | F-InKind | D | 541 | 4.30 | 2,326.00 |
| 2023-06-01 | Krishnamohan Neha | officer: Chief Financial Officer | 68,511 | F-InKind | D | 1,459 | 4.30 | 6,274.00 |
| 2023-05-08 | Tananbaum James B. | director, 10 percent owner: | 3,525,957 | P-Purchase | A | 1,550,956 | 2.80 | 4,342,677.00 |
| 2023-05-08 | Tananbaum James B. | director, 10 percent owner: | 520,711 | P-Purchase | A | 229,044 | 2.80 | 641,323.00 |
| 2023-05-08 | Foresite Capital Management IV, LLC | 10 percent owner | 3,525,957 | P-Purchase | A | 1,550,956 | 2.80 | 4,342,677.00 |
| 2023-05-08 | Foresite Capital Management IV, LLC | 10 percent owner | 520,711 | P-Purchase | A | 229,044 | 2.80 | 641,323.00 |
| 2023-05-04 | ORBIMED ADVISORS LLC | director, 10 percent owner: | 4,738,453 | P-Purchase | A | 312,991 | 2.75 | 860,725.00 |
| 2023-05-05 | ORBIMED ADVISORS LLC | director, 10 percent owner: | 1,368,339 | P-Purchase | A | 490,512 | 2.82 | 1,383,244.00 |
| 2023-05-05 | ORBIMED ADVISORS LLC | director, 10 percent owner: | 1,368,338 | P-Purchase | A | 490,511 | 2.82 | 1,383,241.00 |
| 2023-05-04 | ORBIMED ADVISORS LLC | director, 10 percent owner: | 877,827 | P-Purchase | A | 83,459 | 2.75 | 229,512.00 |
| 2023-05-04 | GORDON CARL L | director, 10 percent owner: | 4,738,453 | P-Purchase | A | 312,991 | 2.75 | 860,725.00 |
| 2023-05-05 | GORDON CARL L | director, 10 percent owner: | 1,368,339 | P-Purchase | A | 490,512 | 2.82 | 1,383,244.00 |
| 2023-05-05 | GORDON CARL L | director, 10 percent owner: | 1,368,338 | P-Purchase | A | 490,511 | 2.82 | 1,383,241.00 |
| 2023-05-04 | GORDON CARL L | director, 10 percent owner: | 877,827 | P-Purchase | A | 83,459 | 2.75 | 229,512.00 |
| 2023-05-02 | GORDON CARL L | director, 10 percent owner: | 4,425,462 | P-Purchase | A | 220,610 | 2.67 | 589,029.00 |
| 2023-05-01 | GORDON CARL L | director, 10 percent owner: | 4,204,852 | P-Purchase | A | 467,068 | 2.62 | 1,223,718.00 |
| 2023-04-28 | GORDON CARL L | director, 10 percent owner: | 3,737,784 | P-Purchase | A | 228,754 | 2.55 | 583,323.00 |
| 2023-05-02 | GORDON CARL L | director, 10 percent owner: | 794,368 | P-Purchase | A | 58,826 | 2.67 | 157,065.00 |
| 2023-05-01 | GORDON CARL L | director, 10 percent owner: | 735,542 | P-Purchase | A | 124,545 | 2.62 | 326,308.00 |
| 2023-04-28 | GORDON CARL L | director, 10 percent owner: | 610,998 | P-Purchase | A | 60,998 | 2.55 | 155,545.00 |
| 2023-04-28 | GORDON CARL L | director, 10 percent owner: | 610,997 | P-Purchase | A | 60,997 | 2.55 | 155,542.00 |
| 2023-05-02 | ORBIMED ADVISORS LLC | director, 10 percent owner: | 4,425,462 | P-Purchase | A | 220,610 | 2.67 | 589,029.00 |
| 2023-05-01 | ORBIMED ADVISORS LLC | director, 10 percent owner: | 4,204,852 | P-Purchase | A | 467,068 | 2.62 | 1,223,718.00 |
| 2023-04-28 | ORBIMED ADVISORS LLC | director, 10 percent owner: | 3,737,784 | P-Purchase | A | 228,754 | 2.55 | 583,323.00 |
| 2023-05-02 | ORBIMED ADVISORS LLC | director, 10 percent owner: | 794,368 | P-Purchase | A | 58,826 | 2.67 | 157,065.00 |
| 2023-05-01 | ORBIMED ADVISORS LLC | director, 10 percent owner: | 735,542 | P-Purchase | A | 124,545 | 2.62 | 326,308.00 |
| 2023-04-28 | ORBIMED ADVISORS LLC | director, 10 percent owner: | 610,998 | P-Purchase | A | 60,998 | 2.55 | 155,545.00 |
| 2023-04-28 | ORBIMED ADVISORS LLC | director, 10 percent owner: | 610,997 | P-Purchase | A | 60,997 | 2.55 | 155,542.00 |
| 2023-03-01 | Williams Richard Thomas | officer: Chief Medical Officer | 67,295 | F-InKind | D | 638 | 5.21 | 3,324.00 |
| 2023-03-01 | Meltz Mark A | officer: COO General Counsel Secretary | 27,286 | F-InKind | D | 638 | 5.21 | 3,324.00 |
| 2023-03-01 | Krishnamohan Neha | officer: Chief Financial Officer | 67,378 | F-InKind | D | 1,721 | 5.21 | 8,966.00 |
| 2023-03-01 | DeSimone Jill | director | 50,000 | A-Award | A | 50,000 | 5.21 | 260,500.00 |
| 2023-03-01 | DeSimone Jill | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2023-02-17 | ORBIMED ADVISORS LLC | director, 10 percent owner: | 550,000 | A-Award | A | 550,000 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
